Literature DB >> 31250073

CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive memory extinction.

Natália Gonczarowska1,2, Carlos Tomaz1,2,3, Fabio V Caixeta2, Renato Malcher-Lopes2, Marilia Barros1,4, Hisao Nishijo5, Rafael S Maior6,7.   

Abstract

RATIONALE: The endocannabinoid system (eCS) is an important modulator of social anxiety and social reward, as well as memory functions.
OBJECTIVES: The present study evaluated the role of eCS in social interactions and aversive memory extinction in capuchin monkeys (Sapajus spp.) by blocking the cannabinoid type 1 receptor (CB1r).
METHODS: In experiment 1, spontaneous social and non-social behaviors of five capuchin males, each one living in triads with two other females, were observed after AM251 treatment (vehicle, 0.3, 1.0, and 3.0 mg/kg; i.m.). In experiment 2, seven male capuchin monkeys were trained to reach for a reward inside a wooden box. After training, they were given either vehicle or a 3.0-mg/kg i.m. dose of AM251 before a single aversive encounter with a live snake in the box. The latency to return to reach the reward inside the box in subsequent trials was measured.
RESULTS: The 3.0-mg/kg dose significantly increased the time spent performing self-directed behaviors, while decreasing that of social interactions. No changes were observed in vigilance or locomotion. AM251 increased the latency to reach the reward after the aversive encounter.
CONCLUSION: Taken together, these results suggest that CB1r antagonism induces social deficits without increasing anxiety levels and impairs the extinction of aversive memories. This behavioral profile in monkeys underscores the potential involvement of eCS signaling in the deficits observed in autism spectrum disorders.

Entities:  

Keywords:  AM-251; Aversive memory; Capuchin monkey; Endocannabinoid system; Social interaction

Mesh:

Substances:

Year:  2019        PMID: 31250073     DOI: 10.1007/s00213-019-05305-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

2.  Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory.

Authors:  Lucas de Oliveira Alvares; Douglas Senna Engelke; Felipe Diehl; Robson Scheffer-Teixeira; Josué Haubrich; Lindsey de Freitas Cassini; Victor Alejandro Molina; Jorge Alberto Quillfeldt
Journal:  Learn Mem       Date:  2010-03-26       Impact factor: 2.460

Review 3.  Observational study of behavior: sampling methods.

Authors:  J Altmann
Journal:  Behaviour       Date:  1974       Impact factor: 1.991

Review 4.  Non-human primate models for investigating fear and anxiety.

Authors:  Marilia Barros; Carlos Tomaz
Journal:  Neurosci Biobehav Rev       Date:  2002-03       Impact factor: 8.989

5.  Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.

Authors:  J Haller; B Varga; C Ledent; I Barna; T F Freund
Journal:  Eur J Neurosci       Date:  2004-04       Impact factor: 3.386

6.  Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.

Authors:  V M Doenni; J M Gray; C M Song; S Patel; M N Hill; Q J Pittman
Journal:  Brain Behav Immun       Date:  2016-07-21       Impact factor: 7.217

7.  Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.

Authors:  Alexandre Seillier; Alex A Martinez; Andrea Giuffrida
Journal:  Neuropsychopharmacology       Date:  2013-04-05       Impact factor: 7.853

8.  Cannabinoid modulation of amygdala reactivity to social signals of threat in humans.

Authors:  K Luan Phan; Mike Angstadt; Jamie Golden; Ikechukwu Onyewuenyi; Ana Popovska; Harriet de Wit
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

9.  Plasma anandamide concentrations are lower in children with autism spectrum disorder.

Authors:  Debra S Karhson; Karolina M Krasinska; Jamie Ahloy Dallaire; Robin A Libove; Jennifer M Phillips; Allis S Chien; Joseph P Garner; Antonio Y Hardan; Karen J Parker
Journal:  Mol Autism       Date:  2018-03-12       Impact factor: 7.509

Review 10.  The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.

Authors:  Erica Zamberletti; Marina Gabaglio; Daniela Parolaro
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

View more
  2 in total

Review 1.  Combinatorial approaches for treating neuropsychiatric social impairment.

Authors:  Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

Review 2.  The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics.

Authors:  Mashal Ahmed; Isabelle Boileau; Bernard Le Foll; Andre F Carvalho; Stefan Kloiber
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.